FMR LLC 315066 Data last updated 2024-05-11 06:58:14 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-26 | 2023-05-19 | 3 | Fmr Llc | SEE REMARK 1 | holding | 2500000.0 | 0 | 0.0 | Direct | Common Shares Of Beneficial Ownership | FIDELITY MULTI-STRATEGY CREDIT FUND | NA | 0.0 (NONE) | |||
| 2023-06-29 | 2023-06-27 | 4 | Fmr Llc | SEE REMARK 1 | holding | 1280001.754 | 0 | 2693.23 | 0.0 | Direct | Class I Common Shares Of Beneficial Interest | FIDELITY PRIVATE CREDIT FUND | NA | 4.75 (NONE) | ||
| 2023-06-29 | 2023-06-27 | 4 | Fmr Llc | SEE REMARK 1 | holding | 81.288 | 0 | 0.17 | 0.0 | Fmr Capital Inc. | Class I Common Shares Of Beneficial Interest | FIDELITY PRIVATE CREDIT FUND | NA | 4.75 (NONE) | ||
| 2023-06-29 | 2023-06-27 | 2023-06-27 | 4 | Fmr Llc | SEE REMARK 1 | acq | 346722.776 | 100.0 | 729.53 | 25.23 | Fidelity Multi Strategy Credit Fund | Class I Common Shares Of Beneficial Interest | FIDELITY PRIVATE CREDIT FUND | code P | 346722.776 | 4.75 (NONE) |
| 2023-07-27 | 2023-07-25 | 2023-07-25 | 4 | Fmr Llc | SEE REMARK 1 | acq | 832652.0 | 100.0 | 0.0 | F Prime Capital Partners Healthcare Fund V Lp | Common Stock | TURNSTONE BIOLOGICS CORP. | code C | 832652.0
|
0.0 (TSBX) | |
| 2023-07-27 | 2023-07-25 | 2023-07-25 | 4 | Fmr Llc | SEE REMARK 1 | acq | 296396.0 | 100.0 | 0.0 | Impresa Fund Iii Limited Partnership | Common Stock | TURNSTONE BIOLOGICS CORP. | code C | 296396.0 | 0.0 (TSBX) | |
| 2023-07-27 | 2023-07-25 | 2023-07-25 | 4 | Fmr Llc | SEE REMARK 1 | acq | 4939.0 | 100.0 | 0.0 | F Prime Capital Partners Healthcare Advisors Fund V Lp | Common Stock | TURNSTONE BIOLOGICS CORP. | code C | 4939.0 | 0.0 (TSBX) | |
| 2023-09-14 | 2023-09-14 | 3 | Fmr Llc | SEE REMARK 1 | holding | 1911729.0 | 0 | 0.0 | F Prime Capital Partners Life Sciences Fund Vii Lp | Common Stock | NEUMORA THERAPEUTICS, INC. | NA | 0.0 (NMRA) | |||
| 2023-09-21 | 2023-09-19 | 4 | Fmr Llc | SEE REMARK 1 | holding | 1911729.0 | 0 | 0.0 | F Prime Capital Partners Life Sciences Fund Vii Lp | Common Stock | NEUMORA THERAPEUTICS, INC. | NA | 0.0 (NMRA) | |||
| 2023-09-21 | 2023-09-19 | 2023-09-19 | 4 | Fmr Llc | SEE REMARK 1 | acq | 3560611.0 | 65.07 | 0.0 | F Prime Capital Partners Life Sciences Fund Vii Lp | Common Stock | NEUMORA THERAPEUTICS, INC. | code C | 5472340.0
|
0.0 (NMRA) | |
| 2023-09-21 | 2023-09-19 | 2023-09-19 | 4 | Fmr Llc | SEE REMARK 1 | acq | 88289.0 | 100.0 | 0.0 | Fbri Llc | Common Stock | NEUMORA THERAPEUTICS, INC. | code C | 88289.0 | 0.0 (NMRA) | |
| 2023-09-21 | 2023-09-19 | 2023-09-19 | 4 | Fmr Llc | SEE REMARK 1 | acq | 63724.0 | 100.0 | 0.0 | F Prime Inc. | Common Stock | NEUMORA THERAPEUTICS, INC. | code C | 63724.0 | 0.0 (NMRA) | |
| 2023-10-12 | 2023-10-02 | 3 | Fmr Llc | SEE REMARK 1 | holding | 723837.0 | 0 | 63.05 | 0.0 | F Prime Capital Partners Life Sciences Fund Vi Lp | Ordinary Shares | STRUCTURE THERAPEUTICS INC. | NA | 114.81 (GPCR) | ||
| 2023-10-12 | 2023-10-02 | 3 | Fmr Llc | SEE REMARK 1 | holding | 61527.0 | 0 | 5.36 | 0.0 | F Prime Capital Partners Life Sciences Advisors Fund Vi Lp | Ordinary Shares | STRUCTURE THERAPEUTICS INC. | NA | 114.81 (GPCR) | ||
| 2023-10-23 | 2023-10-18 | 4 | Fmr Llc | SEE REMARK 1 | holding | 530814.0 | 0 | 46.24 | 0.0 | F Prime Capital Partners Life Sciences Fund Vi Lp | Ordinary Shares | STRUCTURE THERAPEUTICS INC. | NA | 114.81 (GPCR) | ||
| 2023-10-23 | 2023-10-18 | 4 | Fmr Llc | SEE REMARK 1 | holding | 45120.0 | 0 | 3.93 | 0.0 | F Prime Capital Partners Life Sciences Advisors Fund Vi Lp | Ordinary Shares | STRUCTURE THERAPEUTICS INC. | NA | 114.81 (GPCR) | ||
| 2023-11-29 | 2023-11-29 | 2023-11-29 | 4 | Fmr Llc | SEE REMARK 1 | acq | 391.495 | 100.0 | 25.54 | Fmr Capital Inc. | Class S Common Shares Of Beneficial Interest | FIDELITY PRIVATE CREDIT FUND | code P | 391.495 | 0.0 (NONE) | |
| 2023-11-29 | 2023-11-29 | 2023-11-29 | 4 | Fmr Llc | SEE REMARK 1 | acq | 391.495 | 100.0 | 25.54 | Fmr Capital Inc. | Class D Common Shares Of Beneficial Interest | FIDELITY PRIVATE CREDIT FUND | code P | 391.495 | 0.0 (NONE) | |
| 2023-11-29 | 2023-11-29 | 4 | Fmr Llc | SEE REMARK 1 | holding | 1280001.754 | 0 | 1011.03 | 0.0 | Direct | Class I Common Shares Of Beneficial Interest | FIDELITY PRIVATE CREDIT FUND | NA | 12.66 (NONE) | ||
| 2023-11-29 | 2023-11-29 | 4 | Fmr Llc | SEE REMARK 1 | holding | 352359.548 | 0 | 278.32 | 0.0 | Fidelity Multi Strategy Credit Fund | Class I Common Shares Of Beneficial Interest | FIDELITY PRIVATE CREDIT FUND | NA | 12.66 (NONE) | ||
| 2023-11-29 | 2023-11-29 | 4 | Fmr Llc | SEE REMARK 1 | holding | 84.684 | 0 | 0.07 | 0.0 | Fmr Capital Inc. | Class I Common Shares Of Beneficial Interest | FIDELITY PRIVATE CREDIT FUND | NA | 12.66 (NONE) | ||
| 2023-12-07 | 2023-12-05 | 4 | Fmr Llc | SEE REMARK 1 | holding | 45120.0 | 0 | 3.24 | 0.0 | F Prime Capital Partners Life Sciences Advisors Fund Vi Lp | Ordinary Shares | STRUCTURE THERAPEUTICS INC. | NA | 139.16 (GPCR) | ||
| 2023-12-07 | 2023-12-05 | 4 | Fmr Llc | SEE REMARK 1 | holding | 530814.0 | 0 | 38.14 | 0.0 | F Prime Capital Partners Life Sciences Fund Vi Lp | Ordinary Shares | STRUCTURE THERAPEUTICS INC. | NA | 139.16 (GPCR) | ||
| 2023-12-27 | 2023-12-22 | 4 | Fmr Llc | SEE REMARK 1 | holding | 45120.0 | 0 | 3.24 | 0.0 | F Prime Capital Partners Life Sciences Advisors Fund Vi Lp | Ordinary Shares | STRUCTURE THERAPEUTICS INC. | NA | 139.16 (GPCR) | ||
| 2023-12-27 | 2023-12-22 | 4 | Fmr Llc | SEE REMARK 1 | holding | 530814.0 | 0 | 38.14 | 0.0 | F Prime Capital Partners Life Sciences Fund Vi Lp | Ordinary Shares | STRUCTURE THERAPEUTICS INC. | NA | 139.16 (GPCR) | ||
| 2023-12-27 | 2023-12-22 | 4 | Fmr Llc | SEE REMARK 1 | holding | 2135511.0 | 0 | 262.01 | 0.0 | F Prime Capital Partners Healthcare Fund V Lp | Common Stock | BEAM THERAPEUTICS INC. | NA | 81.5 (BEAM) | ||
| 2023-12-27 | 2023-12-22 | 2023-12-22 | 4 | Fmr Llc | SEE REMARK 1 | dsp | 29549.0 | 1.05 | 3.63 | 0.0 | Shares Held By Persons And Entities Whose Shares Are Subject To Reporting By The Undersigned | Common Stock | BEAM THERAPEUTICS INC. | code J | 2773478.0 | 81.5 (BEAM) |
| 2024-01-11 | 2024-01-09 | 4 | Fmr Llc | SEE REMARK 1 | holding | 4939.0 | 0 | 2.14 | 0.0 | F Prime Capital Partners Healthcare Advisors Fund V Lp | Common Stock | TURNSTONE BIOLOGICS CORP. | NA | 23.09 (TSBX) | ||
| 2024-01-11 | 2024-01-09 | 4 | Fmr Llc | SEE REMARK 1 | holding | 296396.0 | 0 | 128.35 | 0.0 | Impresa Fund Iii Limited Partnership | Common Stock | TURNSTONE BIOLOGICS CORP. | NA | 23.09 (TSBX) | ||
| 2024-01-11 | 2024-01-09 | 4 | Fmr Llc | SEE REMARK 1 | holding | 832652.0 | 0 | 360.56 | 0.0 | F Prime Capital Partners Healthcare Fund V Lp | Common Stock | TURNSTONE BIOLOGICS CORP. | NA | 23.09 (TSBX) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-07-20 | 2023-07-20 | 3 | Fmr Llc | SEE REMARK 1 | holding | 150809.0 | 0 | 0.0 | F Prime Capital Partners Healthcare Fund V Lp | Series B 2 Preferred Stock | TURNSTONE BIOLOGICS CORP. | NA | 0.0 (TSBX) | |||
| 2023-07-20 | 2023-07-20 | 3 | Fmr Llc | SEE REMARK 1 | holding | 4939.0 | 0 | 0.0 | F Prime Capital Partners Healthcare Advisors Fund V Lp | Series B 2 Preferred Stock | TURNSTONE BIOLOGICS CORP. | NA | 0.0 (TSBX) | |||
| 2023-07-20 | 2023-07-20 | 3 | Fmr Llc | SEE REMARK 1 | holding | 296396.0 | 0 | 0.0 | Impresa Fund Iii Limited Partnership | Series B 2 Preferred Stock | TURNSTONE BIOLOGICS CORP. | NA | 0.0 (TSBX) | |||
| 2023-07-20 | 2023-07-20 | 3 | Fmr Llc | SEE REMARK 1 | holding | 91663.0 | 0 | 0.0 | F Prime Capital Partners Healthcare Fund V Lp | Series D Preferred Stock | TURNSTONE BIOLOGICS CORP. | NA | 0.0 (TSBX) | |||
| 2023-07-20 | 2023-07-20 | 3 | Fmr Llc | SEE REMARK 1 | holding | 106496.0 | 0 | 0.0 | F Prime Capital Partners Healthcare Fund V Lp | Series C Preferred Stock | TURNSTONE BIOLOGICS CORP. | NA | 0.0 (TSBX) | |||
| 2023-07-20 | 2023-07-20 | 3 | Fmr Llc | SEE REMARK 1 | holding | 483684.0 | 0 | 0.0 | F Prime Capital Partners Healthcare Fund V Lp | Series B 1 Preferred Stock | TURNSTONE BIOLOGICS CORP. | NA | 0.0 (TSBX) | |||
| 2023-07-27 | 2023-07-25 | 2023-07-25 | 4 | Fmr Llc | SEE REMARK 1 | dsp | 91663.0 | 100.0 | 0.0 | F Prime Capital Partners Healthcare Fund V Lp | Series D Preferred Stock | TURNSTONE BIOLOGICS CORP. | code C | 0.0 | 0.0 (TSBX) | |
| 2023-07-27 | 2023-07-25 | 2023-07-25 | 4 | Fmr Llc | SEE REMARK 1 | dsp | 483684.0 | 100.0 | 0.0 | F Prime Capital Partners Healthcare Fund V Lp | Series B 1 Preferred Stock | TURNSTONE BIOLOGICS CORP. | code C | 0.0 | 0.0 (TSBX) | |
| 2023-07-27 | 2023-07-25 | 2023-07-25 | 4 | Fmr Llc | SEE REMARK 1 | dsp | 4939.0 | 100.0 | 0.0 | F Prime Capital Partners Healthcare Advisors Fund V Lp | Series B 2 Preferred Stock | TURNSTONE BIOLOGICS CORP. | code C | 0.0 | 0.0 (TSBX) | |
| 2023-07-27 | 2023-07-25 | 2023-07-25 | 4 | Fmr Llc | SEE REMARK 1 | dsp | 150809.0 | 100.0 | 0.0 | F Prime Capital Partners Healthcare Fund V Lp | Series B 2 Preferred Stock | TURNSTONE BIOLOGICS CORP. | code C | 0.0 | 0.0 (TSBX) | |
| 2023-07-27 | 2023-07-25 | 2023-07-25 | 4 | Fmr Llc | SEE REMARK 1 | dsp | 296396.0 | 100.0 | 0.0 | Impresa Fund Iii Limited Partnership | Series B 2 Preferred Stock | TURNSTONE BIOLOGICS CORP. | code C | 0.0 | 0.0 (TSBX) | |
| 2023-07-27 | 2023-07-25 | 2023-07-25 | 4 | Fmr Llc | SEE REMARK 1 | dsp | 106496.0 | 100.0 | 0.0 | F Prime Capital Partners Healthcare Fund V Lp | Series C Preferred Stock | TURNSTONE BIOLOGICS CORP. | code C | 0.0 | 0.0 (TSBX) | |
| 2023-09-14 | 2023-09-14 | 3 | Fmr Llc | SEE REMARK 1 | holding | 84965.0 | 0 | 0.0 | F Prime Capital Partners Life Sciences Fund Vii Lp | Series B Preferred Stock | NEUMORA THERAPEUTICS, INC. | NA | 0.0 (NMRA) | |||
| 2023-09-14 | 2023-09-14 | 3 | Fmr Llc | SEE REMARK 1 | holding | 88289.0 | 0 | 0.0 | Fbri Llc | Series A 2 Preferred Stock | NEUMORA THERAPEUTICS, INC. | NA | 0.0 (NMRA) | |||
| 2023-09-14 | 2023-09-14 | 3 | Fmr Llc | SEE REMARK 1 | holding | 63724.0 | 0 | 0.0 | F Prime Inc. | Series A 2 Preferred Stock | NEUMORA THERAPEUTICS, INC. | NA | 0.0 (NMRA) | |||
| 2023-09-14 | 2023-09-14 | 3 | Fmr Llc | SEE REMARK 1 | holding | 3475646.0 | 0 | 0.0 | F Prime Capital Partners Life Sciences Fund Vii Lp | Series A 2 Preferred Stock | NEUMORA THERAPEUTICS, INC. | NA | 0.0 (NMRA) | |||
| 2023-09-21 | 2023-09-19 | 2023-09-19 | 4 | Fmr Llc | SEE REMARK 1 | dsp | 3475646.0 | 100.0 | 0.0 | F Prime Capital Partners Life Sciences Fund Vii Lp | Series A 2 Preferred Stock | NEUMORA THERAPEUTICS, INC. | code C | 0.0 | 0.0 (NMRA) | |
| 2023-09-21 | 2023-09-19 | 2023-09-19 | 4 | Fmr Llc | SEE REMARK 1 | dsp | 88289.0 | 100.0 | 0.0 | Fbri Llc | Series A 2 Preferred Stock | NEUMORA THERAPEUTICS, INC. | code C | 0.0 | 0.0 (NMRA) | |
| 2023-09-21 | 2023-09-19 | 2023-09-19 | 4 | Fmr Llc | SEE REMARK 1 | dsp | 63724.0 | 100.0 | 0.0 | F Prime Inc. | Series A 2 Preferred Stock | NEUMORA THERAPEUTICS, INC. | code C | 0.0 | 0.0 (NMRA) | |
| 2023-09-21 | 2023-09-19 | 2023-09-19 | 4 | Fmr Llc | SEE REMARK 1 | dsp | 84965.0 | 100.0 | 0.0 | F Prime Capital Partners Life Sciences Fund Vii Lp | Series B Preferred Stock | NEUMORA THERAPEUTICS, INC. | code C | 0.0 | 0.0 (NMRA) | |
| 2023-10-12 | 2023-10-02 | 3 | Fmr Llc | SEE REMARK 1 | holding | 123.0 | 0 | 0.01 | 0.0 | Fimm, Llc | American Depository Shares | STRUCTURE THERAPEUTICS INC. | NA | 114.81 (GPCR) | ||
| 2023-10-12 | 2023-10-02 | 3 | Fmr Llc | SEE REMARK 1 | holding | 4769400.0 | 0 | 415.43 | 0.0 | Shares Held By Persons And Entities Whose Shares Are Subject To Reporting By The Undersigned | American Depository Shares | STRUCTURE THERAPEUTICS INC. | NA | 114.81 (GPCR) | ||
| 2023-10-23 | 2023-10-18 | 4 | Fmr Llc | SEE REMARK 1 | holding | 1589800.0 | 0 | 138.48 | 0.0 | Shares Held By Persons And Entities Whose Shares Are Subject To Reporting By The Undersigned | American Depositary Shares | STRUCTURE THERAPEUTICS INC. | NA | 114.81 (GPCR) | ||
| 2023-10-23 | 2023-10-18 | 2023-10-18 | 4 | Fmr Llc | SEE REMARK 1 | dsp | 16086.0 | 25.0 | 1.4 | 65.64 | F Prime Capital Partners Life Sciences Fund Vi Lp | American Depositary Shares | STRUCTURE THERAPEUTICS INC. | code S | 48255.0 | 114.81 (GPCR) |
| 2023-10-23 | 2023-10-18 | 4 | Fmr Llc | SEE REMARK 1 | holding | 41.0 | 0 | 0.0 | 0.0 | Fimm, Llc | American Depositary Shares | STRUCTURE THERAPEUTICS INC. | NA | 114.81 (GPCR) | ||
| 2023-10-23 | 2023-10-18 | 2023-10-18 | 4 | Fmr Llc | SEE REMARK 1 | dsp | 1368.0 | 25.01 | 0.12 | 65.64 | F Prime Capital Partners Life Sciences Advisors Fund Vi Lp | American Depositary Shares | STRUCTURE THERAPEUTICS INC. | code S | 4101.0 | 114.81 (GPCR) |
| 2023-12-07 | 2023-12-05 | 4 | Fmr Llc | SEE REMARK 1 | holding | 1589800.0 | 0 | 114.24 | 0.0 | Shares Held By Persons And Entities Whose Shares Are Subject To Reporting By The Undersigned | American Depositary Shares | STRUCTURE THERAPEUTICS INC. | NA | 139.16 (GPCR) | ||
| 2023-12-07 | 2023-12-05 | 2023-12-05 | 4 | Fmr Llc | SEE REMARK 1 | dsp | 1368.0 | 33.36 | 0.1 | 62.46 | F Prime Capital Partners Life Sciences Advisors Fund Vi Lp | American Depositary Shares | STRUCTURE THERAPEUTICS INC. | code S | 2733.0 | 139.16 (GPCR) |
| 2023-12-07 | 2023-12-05 | 4 | Fmr Llc | SEE REMARK 1 | holding | 41.0 | 0 | 0.0 | 0.0 | Fimm, Llc | American Depositary Shares | STRUCTURE THERAPEUTICS INC. | NA | 139.16 (GPCR) | ||
| 2023-12-07 | 2023-12-05 | 2023-12-05 | 4 | Fmr Llc | SEE REMARK 1 | dsp | 16086.0 | 33.34 | 1.16 | 62.46 | F Prime Capital Partners Life Sciences Fund Vi Lp | American Depositary Shares | STRUCTURE THERAPEUTICS INC. | code S | 32169.0 | 139.16 (GPCR) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)